首页> 外文期刊>PACE: Pacing and clinical electrophysiology >A zero-fluoroscopy approach to cavotricuspid isthmus catheter ablation: Comparative analysis of two electroanatomical mapping systems
【24h】

A zero-fluoroscopy approach to cavotricuspid isthmus catheter ablation: Comparative analysis of two electroanatomical mapping systems

机译:零透视法治疗左室峡部峡部导管消融:两种电解剖标测系统的比较分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Electroanatomical mapping systems have reduced the amount of fluoroscopy required to ablate the cavotricuspid isthmus. The aims of this study are to evaluate the feasibility and safety of a zero-fluoroscopy approach to cavotricuspid isthmus catheter ablation using the Carto?3 system (Biosense Webster, Diamond Bar, CA, USA) and to compare the results of this approach with those of the zero-fluoroscopy approach using the Ensite-NavX? system (St. Jude Medical, St. Paul, MN, USA). Methods Twenty consecutive procedures guided by the Carto?3 system (Group A) were compared with two case-control groups matched from 146 procedures guided with the Ensite-NavX? system. Group B consisted of 20 matched procedures from the first 50 procedures performed in the electrophysiology unit, and Group C consisted of 20 matched procedures from the last 50 procedures. Acute success (bidirectional block), complications, and recurrences were analyzed. The procedure times were also compared. Results There were no differences in the rates of acute success (95%, 100%, and 100%, respectively), complications (0%, 5%, and 0%), and recurrences (5.2%, 0%, and 5%) in the three groups. A zero-fluoroscopy approach was attempted in all procedures, and electroanatomical mapping made it possible to successfully avoid fluoroscopy in 90% of the procedures in Group A, 85% in B, and 95% in C. The total procedure time was shorter in Group C. The fluoroscopy and radiofrequency times were not different. Conclusions A zero-fluoroscopy approach to cavotricuspid isthmus catheter ablation using the Carto?3 system is feasible in most procedures. This approach has similar results to the zero-fluoroscopy approach using the Ensite-NavX? system.
机译:背景技术电解剖标测系统减少了消融左室峡部峡部所需的透视检查量。这项研究的目的是评估使用Carto?3系统(Biosense Webster,Diamond Bar,CA,美国)进行零透视检查法治疗左室峡部峡部导管消融的可行性和安全性,并将这种方法的结果与那些方法进行比较。使用Ensite-NavX进行零荧光检查的方法是什么?系统(美国犹他州圣保罗的圣裘德医疗公司)。方法将20例Carto?3系统(A组)指导的连续手术与146例Ensite-NavX?指导的146例手术配对的两个病例对照组进行比较。系统。 B组由电生理单元执行的前50个过程中的20个匹配过程组成,C组由后50个过程中的20个匹配过程组成。分析急性成功(双向传导阻滞),并发症和复发。还比较了手术时间。结果急性成功率(分别为95%,100%和100%),并发症(0%,5%和0%)和复发率(5.2%,0%和5%)没有差异。 )分为三组。在所有程序中都尝试了零荧光检查方法,并且通过电解剖图可以成功避免A组90%,B组85%和C组95%的程序进行荧光检查。组的总手术时间较短C.透视和射频时间没有不同。结论在大多数手术中,使用Carto?3系统进行零荧光透视术治疗左室峡部峡部导管消融是可行的。这种方法的结果与使用Ensite-NavX?的零荧光检查法相似。系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号